This is some good bedtime reading, thanks RBx. This has massive potential, particularly given the amount of mutation we're seeing in COVID. And that's not even considering the immune disease applications.
A reminder of what GK said at the AGM (paraphrasing):
"Six months ago, an esteemed international professor in immunology said if I did nothing else in my life, I needed to get my hands on Hudson's RNA technology. That is what we have now done."
Pharmorage, page-3
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
